- Citations, last 5 years
- 12.5k
- Works, last 5 years
- 2 121
- h-index
- 388
- Scientists listed
- 0
- Grants since 2016
- 432
Grants received
2016–2018 · research · R21
Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology
Patrik Brundin · Van Andel Institute · funded by National Institutes of Health
2016 · research · Target Advancement Program
Alpha-synuclein-induced Astroglial Inflammation as a Trigger of Parkinson's Disease
Laurent Roybon · Van Andel Institute · funded by Michael J. Fox Foundation for Parkinson's Research
2016–2022 · research · R01
Role of GAS41 in Human Cancer
Xiaobing Shi · Van Andel Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U24
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
Benjamin P Berman · Van Andel Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U24
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
Benjamin P Berman · Van Andel Institute · funded by National Institutes of Health
2016 · award
Altered glycolysis & mitochondrial lipid content drive evasion of apoptosis
Kristin Dittenhafer-Reed · Van Andel Institute · funded by American Cancer Society
2016–2021 · research · R01
Role of GAS41 in Human Cancer
Xiaobing Shi · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
Patrick J Grohar · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Breast Cancer Risk Enhancers
Gerhard A Coetzee · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
Darren John Moore · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
Darren John Moore · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Breast Cancer Risk Enhancers
Gerhard A Coetzee · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Breast Cancer Risk Enhancers
Gerhard A Coetzee · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
Darren John Moore · Van Andel Institute · funded by National Institutes of Health
2015–2021 · research · R01
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
Darren John Moore · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
Patrick J Grohar · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
Patrick J Grohar · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Breast Cancer Risk Enhancers
Gerhard A Coetzee · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
Patrick J Grohar · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer
William S Hlavacek · Van Andel Institute · funded by National Institutes of Health
2015–2020 · research · R01
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
Darren John Moore · Van Andel Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2010–2023 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2010–2023 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U01
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
Peter J Allen · Van Andel Institute · funded by National Institutes of Health
2007–2023 · research · R01
Structural biology of proteostasis in M. tuberculosis
Huilin Li · Van Andel Institute · funded by National Institutes of Health
2007–2023 · research · R01
Structural biology of proteostasis in M. tuberculosis
Huilin Li · Van Andel Institute · funded by National Institutes of Health
2007–2023 · research · R01
Structural biology of proteostasis in M. tuberculosis
Huilin Li · Van Andel Institute · funded by National Institutes of Health
2007–2023 · research · R01
Structural biology of proteostasis in M. tuberculosis
Huilin Li · Van Andel Institute · funded by National Institutes of Health
2007–2023 · research · R01
Structural biology of proteostasis in M. tuberculosis
Huilin Li · Van Andel Institute · funded by National Institutes of Health